Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy

To study the impact of infusion therapy with the metabolic modulator remaxol on lipid metabolic parameters and target organ (liver, kidney) function in metabolic syndrome (MS). The investigation enrolled 90 patients (54 men and 36 women) with primary nonalcoholic steatohepatitis that was associated...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Terapevtic̆eskii arhiv Ročník 85; číslo 4; s. 71 - 76
Hlavní autori:	Stel'makh, V V, Kozlov, V K
Médium:	Journal Article
Jazyk:	Russian
Vydavateľské údaje:	Russia (Federation) "Consilium Medicum" Publishing house 01.01.2013
Predmet:	Adult Aged diabetic nephropathy dyslipidemia Dyslipidemias - drug therapy Dyslipidemias - metabolism Fatty Liver - drug therapy Fatty Liver - metabolism Female Humans Male metabolic syndrome Metabolic Syndrome - drug therapy Metabolic Syndrome - metabolism Middle Aged Non-alcoholic Fatty Liver Disease nonalcoholic steatohepatitis pathogenetic therapy remaxol S-Adenosylmethionine - administration & dosage S-Adenosylmethionine - pharmacology Succinates - administration & dosage Succinates - pharmacology succinic acid Treatment Outcome Young Adult
ISSN:	0040-3660, 2309-5342
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!